NCT05015049

Brief Summary

Around one in ten women have high blood pressure in pregnancy. This is potentially serious, with risks to the woman and her baby. Whilst maternal deaths from high blood pressure in pregnancy are now rare in the UK, blood pressure problems in pregnancy still cause many stillbirths and early births. Studies have shown that women of Black and Asian backgrounds are more likely to have worse pregnancy outcomes when blood pressure problems in pregnancy develop. This study aims to: i) describe the burden of disease of high blood pressure in pregnancy amongst babies admitted to neonatal units on a national scale. ii) investigate outcomes for babies born to women with high blood pressure in pregnancy admitted to UK neonatal units across maternal ethnic groups. To complete this study, we will use the National Neonatal Research Database, which holds population-level data for all babies admitted to neonatal units (where unwell babies receive care) in the UK. We will look at records of babies admitted to neonatal units in England and Wales between 2012 and 2020. The records will include information on over half a million babies and their mothers. We will assess how many babies admitted to neonatal units were born to women who had high blood pressure in pregnancy. We will report the outcomes of these babies, and how they compare to babies born to women without high blood pressure in pregnancy. We will analyse whether outcomes for babies born to women with high blood pressure in pregnancy varies according to maternal ethnicity, and investigate what may be driving differences we find.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
823,957

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jul 2021

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2021

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

August 10, 2021

Completed
10 days until next milestone

First Posted

Study publicly available on registry

August 20, 2021

Completed
4.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2025

Completed
Last Updated

October 15, 2024

Status Verified

October 1, 2024

Enrollment Period

4.3 years

First QC Date

August 10, 2021

Last Update Submit

October 11, 2024

Conditions

Outcome Measures

Primary Outcomes (4)

  • Survival to discharge from neonatal care

    Survival to discharge from neonatal care

    From birth to discharge or death, assessed up to 1 year

  • Primary recorded reason for neonatal unit admission

    Primary recorded reason for neonatal unit admission

    From birth to discharge or death, assessed up to 1 year

  • Length of stay in neonatal unit

    Length of stay in neonatal unit

    From birth to discharge or death, assessed up to 1 year

  • Number of days of intensive care

    Number of days of intensive care

    From birth to discharge or death, assessed up to 1 year

Secondary Outcomes (20)

  • Survival to discharge from neonatal care without comorbidity

    From birth to discharge or death, assessed up to 1 year

  • Cause of death

    From birth to discharge or death, assessed up to 1 year

  • Age at death

    From birth to discharge or death, assessed up to 1 year

  • Discharge weight SDS (standard deviation score)

    From birth to discharge or death, assessed up to 1 year

  • Birthweight centile (z-score)

    From birth to discharge or death, assessed up to 1 year

  • +15 more secondary outcomes

Study Arms (2)

Neonatal population - hypertensive disorder of pregnancy

All babies born to a woman with a hypertensive disorder of pregnancy (HDP) and admitted to a neonatal unit in England and Wales between 1st January 2012 and 31st December 2020

Neonatal population - no hypertensive disorder of pregnancy

All babies born to a woman without a hypertensive disorder of pregnancy (HDP) and admitted to a neonatal unit in England and Wales between 1st January 2012 and 31st December 2020

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Babies born between 1st January 2012 and 31st December 2020 and admitted to a neonatal unit in England or Wales

You may qualify if:

  • Must be born between 1st January 2012 and 31st December 2020
  • Must be admitted to and received all care in a National Health Service (NHS) neonatal unit in England or Wales

You may not qualify if:

  • None

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Imperial College London

London, United Kingdom

Location

MeSH Terms

Conditions

Hypertension, Pregnancy-Induced

Condition Hierarchy (Ancestors)

Pregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesHypertensionVascular DiseasesCardiovascular Diseases

Study Officials

  • Cheryl Battersby

    Imperial College London

    PRINCIPAL INVESTIGATOR
  • Lucy Chappell

    King's College London

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 10, 2021

First Posted

August 20, 2021

Study Start

July 1, 2021

Primary Completion

September 30, 2025

Study Completion

September 30, 2025

Last Updated

October 15, 2024

Record last verified: 2024-10

Locations